A sub analysis of Val-HeFT (valsartan in HF) trial indicated that high hsCRP (highly sensitive C reactive protein) concentrations are independently associated with mortality and morbidity, with incremental prognostic value to that provided by B type natriuretic peptide alone [7]. Here, CRP is linked to hydrops fetalis.